Pediatricians Call on DEA to Reschedule; Allow For Sick Kids to Access Marijuana
Pediatricians are calling on the Drug Enforcement Administration to ease federal restrictions on marijuana so that very sick children can access medical cannabis’s benefits.
Like most everyone else in mainstream medicine, the American Academy of Pediatrics is staunchly opposed to marijuana legalization, and doesn’t think much of medical cannabis administered via a joint or blunt.
However, the academy in January recognized that children are indeed receiving relief from oils and marijuana in other forms, and called for the DEA to ease up in order to make it easier for sick kids to access medicine — specifically, pharmaceutical cannnabinoids not in plant form.
Despite mounting evidence that marijuana is efficacious in treating childhood epilepsy as well as forms of cancers, cannabis is still a Schedule I controlled substance. That means the government officially declares it devoid of medical value and highly-addictive.
That also stifles any research. The pediatricians want cannabis put in Schedule II — where you can find methamphetamine and cocaine — so that research can advance more easily.
“The APP strongly supports research and development of pharmaceutical cannabinoids,” the organization wrote in its updated policy statement “The Impact of Marijuana Upon Youth.”
Pediatricians are also warming to giving weed to kids in dire situations. “Notwithstanding this opposition to use, the AAP recognizes that marijuana may currently be an option for cannabinoid administration for children with life-limiting or severely debilitating conditions and for whom current therapies are inadequate,” the policy statement reads.
That’s dry language, but about as full-throated an endorsement yet from the medical establishment of a novel notion: that marijuana is indeed medicine.